Trial Profile
A randomised open comparision of intravaginal APL202 (25 or 50 µg) followed by 25 µg after 4 and 8 hours versus 3 mg of dinoprostone as a vaginal tablet followed by 3 mg after 6 hours in the induction of labour in nulliparous subjects.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2014
Price :
$35
*
At a glance
- Drugs Misoprostol (Primary) ; Dinoprostone
- Indications Labour disorders
- Focus Registrational; Therapeutic Use
- Sponsors Alliance Pharmaceuticals Limited
- 23 Jan 2010 New trial record